Italian Systemic Ophthalmology Network: MediciOculisti.it EyeLongevity.it OculisticaSistemica.it MicrobiotaOculare.it NutrizioneOculistica.it
IT | EN

Ocular Microbiome Test Execution

Operational guide to molecular diagnostics: procedures, clinical indications, indicative lab costs and access.

The ocular microbiota test is an advanced genetic analysis. Unlike traditional cultures that attempt to “grow” bacteria in a lab, this test reads their DNA fragments directly, helping to identify even rare or hard‑to‑culture microorganisms.

Operational Process

1. Outpatient Sampling

Execution of a sterile conjunctival swab. The procedure is quick, non‑invasive, requires no anaesthesia and is generally painless.

2. DNA Stabilization

The sample is immediately placed in a “DNA Shield” reagent tube to preserve genetic integrity during transport.

3. Genetic Sequencing

In an external lab, DNA is extracted and analysed. Depending on the test (Target PCR or Metagenomic NGS), a predefined pathogen list is searched or the entire microbial genome is mapped.

4. Clinical Report

The doctor receives a bioinformatic report listing detected species and potential antibiotic resistance genes, which can support clinical decision‑making.

Information Note on Fees and Diagnostics

The genomic tests described are second‑level external laboratory investigations. The costs reported on this page are for informational purposes only, derived from average public fees applied by molecular biology laboratories available online, and do not constitute a commercial price list of our medical practice. The test is prescribed only after a clinical appropriateness evaluation by the specialist.

Levels of Investigation

There are two main approaches to molecular investigation. The choice is guided by the patient’s clinical picture.

FAST & SPECIFIC

PCR Panel (Targeted Search)

Analysis: Specifically searches for a list of 8‑12 known pathogens.

Clinical indications: Suspected acute infections (sudden red eye, discharge), suspected Herpes or Adenovirus, monitoring in contact lens wearers.

Lab turnaround: About 72 hours from sample receipt.

Rapid response to confirm a specific clinical suspicion and support targeted therapy decisions.

Indicative cost (external labs): around €90 (average online fees).
COMPLETE & DEEP

Metagenomics (Full Mapping)

Analysis: Sequences all microbial DNA present. Detects bacteria, fungi, viruses and parasites beyond a fixed list.

Clinical indications: Chronic conditions (severe Dry Eye, recurrent Blepharitis), cases refractory to standard therapies, suspected ocular dysbiosis.

Lab turnaround: 10‑15 working days.

Comprehensive view of the surface ecosystem and detection of potential resistance genes.

Indicative cost (external labs): €180‑240 (panel‑dependent).

Laboratory Comparison: Time and Cost

Analysis Type Turnaround Time Avg. Lab Fee Clinical Evaluation
PCR Panel (Targeted Search)
Targeted search
 About 72h from receipt ≈ €90 Suspected specific acute infections (e.g., Herpes, Adenovirus).
Metagenomics (Full Mapping)
Complete mapping
 10‑15 days working days €180‑240 Chronic conditions, dysbiosis, refractory in‑depth investigations.

Ethical note: the costs shown are indicative only, derived from public fees of specialised laboratories available online, and do not constitute a commercial offer or private practice service of the network doctors. Times run from sample arrival at the analysis site.

Technical Limits and Future Perspectives

Current Diagnostic Challenges

  • High sensitivity: The technique also detects trace DNA. A poorly isolated sample may show skin bacteria (contamination), requiring interpretative expertise.
  • Clinical interpretation: Detecting a bacterium does not automatically mean it causes the symptom. The ophthalmologist must contextualise the data.
  • Costs: NGS technologies require infrastructure and reagents with significantly higher costs than standard cultures.
  • Evolving therapies: For dysbiosis (unlike acute infections), universally codified therapeutic guidelines are not yet available.

Evolution of Care

  • Point‑of‑care diagnostics: Technological research aims to reduce metagenomic turnaround from weeks to hours.
  • Precision medicine: The goal is to complement broad‑spectrum antibiotics with more selective therapeutic strategies.
  • Ecosystem modulation: Research is exploring topical probiotics or bacterial lysates to support eubiosis restoration.

Access to Testing

The exam requires prescriptive appropriateness and expertise in conjunctival sampling.

Patients at Our Centres

At our Faenza and Ravenna offices, the test is performed within a Systemic Ophthalmology pathway only if considered clinically useful by the specialist.

Contact Dr. Lanfernini